Sino Biopharmaceutical, or SBP, was initially anchored in hepatitis medicines with its flagship drug Tianqing Ganmei, which was approved in 2005 in China. Since the introduction of China’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results